Langbahn Team – Weltmeisterschaft

Dilip Shanghvi: Difference between revisions

Browse history interactively
[accepted revision][accepted revision]
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Monkbot (talk | contribs)
Bots
3,695,952 edits
m →Early life: Task 16: replaced (1×) / removed (0×) deprecated |dead-url= and |deadurl= with |url-status=;
Tag: AWB
Varisgupta251 (talk | contribs)
193 edits
m shanghvi and sanghvi are same meaning but correct and proper spelling is shanghvi
Line 12: Line 12:
| occupation = Founder and MD of [[Sun Pharmaceuticals]]
| occupation = Founder and MD of [[Sun Pharmaceuticals]]
| net worth = US$8.6 billion (January 2019)<ref name="forbes1">{{cite web|url=https://www.forbes.com/profile/dilip-shanghvi/ |title=Dilip Shanghvi |work=Forbes |accessdate= 22 February 2018}}</ref>
| net worth = US$8.6 billion (January 2019)<ref name="forbes1">{{cite web|url=https://www.forbes.com/profile/dilip-shanghvi/ |title=Dilip Shanghvi |work=Forbes |accessdate= 22 February 2018}}</ref>
| spouse = Vibha Sanghvi
| spouse = Vibha Shanghvi
| children = 2
| children = 2
}}
}}
Line 20: Line 20:
== Early life ==
== Early life ==
Dilip Shanghvi hails from a Gujarati Kapol Vaishnav family <ref name=itn>{{cite news|url=https://www.indiatvnews.com/business/india/top-10-gujarati-billionaires-3732.html?page=2|title=Top 10 Gujarati billionaires|date=2015-08-01|publisher=India TV News}}</ref><ref>Das Soma, The Reluctant Billionaire:
Dilip Shanghvi hails from a Gujarati Kapol Vaishnav family <ref name=itn>{{cite news|url=https://www.indiatvnews.com/business/india/top-10-gujarati-billionaires-3732.html?page=2|title=Top 10 Gujarati billionaires|date=2015-08-01|publisher=India TV News}}</ref><ref>Das Soma, The Reluctant Billionaire:
How Dilip Shanghvi Became the Richest Self-Made Indian, 2019, Penguin, {{ISBN|9780670088577}}</ref> family, who was born in the small town of [[Amreli]] in Gujarat to Shantilal Sanghvi and Kumud Sanghvi.<ref name=dna>{{cite news|title=From a drug distributor to global pharma tycoon|url=http://www.dnaindia.com/money/report-from-a-drug-distributor-to-global-pharma-tycoon-1976158|accessdate=9 April 2015|agency=DNA India|date=8 April 2014}}</ref><ref name=ft>{{cite news|title=Dilip Shanghvi’s mother gifts Sun Pharma shares to his wife|url=http://www.financialexpress.com/article/markets/dilip-shanghvis-mother-gifts-sun-pharma-shares-to-his-wife/38877/|accessdate=5 July 2016|agency=Financial Express|date=4 February 2015|archive-url=https://web.archive.org/web/20150926050202/http://www.financialexpress.com/article/markets/dilip-shanghvis-mother-gifts-sun-pharma-shares-to-his-wife/38877/|archive-date=26 September 2015|url-status=dead}}</ref> Shanghvi earned a [[Bachelor of Commerce]] degree from the [[University of Calcutta]].<ref name="Forbes tag">{{cite web|title=Forbes – Dilip Sanghvi|url=https://www.forbes.com/profile/dilip-shanghvi/|publisher=Forbes|accessdate=31 August 2014}}</ref> He spent his childhood and college life with his parents in the [[Burrabazar]] locality of Calcutta. He is an alumnus of [[J. J. Ajmera High School]] and [[Bhawanipur Education Society College]], where he did his schooling and graduation, respectively.<ref>{{cite news|title=The Rise of a Common Man: Dilip Shanghavi - KnowStartup|url=http://knowstartup.com/2015/08/the-rise-of-dilip-shanghavi/|accessdate=19 April 2018|work=KnowStartup|date=4 August 2015}}</ref><ref>{{cite web|title=Dilip Shanghvi- From start up to India's largest drug maker|url=http://www.bigpharmasuccessstories.com/2016/12/07/dilip-shanghvi-from-start-up-to-indias-largest-drug-maker/|accessdate=19 April 2018}}</ref><ref name=zee>{{cite news|title=Govt appoints Dilip Shanghvi, PK Monhanty at RBI’s central board|url=http://www.zeebiz.com/india/news-govt-appoints-dilip-shanghvi-pk-monhanty-at-rbi-s-central-board-35736|accessdate=30 April 2018|work=Zee Business|date=25 January 2018|language=en}}</ref>
How Dilip Shanghvi Became the Richest Self-Made Indian, 2019, Penguin, {{ISBN|9780670088577}}</ref> family, who was born in the small town of [[Amreli]] in Gujarat to Shantilal Shanghvi and Kumud Shanghvi.<ref name=dna>{{cite news|title=From a drug distributor to global pharma tycoon|url=http://www.dnaindia.com/money/report-from-a-drug-distributor-to-global-pharma-tycoon-1976158|accessdate=9 April 2015|agency=DNA India|date=8 April 2014}}</ref><ref name=ft>{{cite news|title=Dilip Shanghvi’s mother gifts Sun Pharma shares to his wife|url=http://www.financialexpress.com/article/markets/dilip-shanghvis-mother-gifts-sun-pharma-shares-to-his-wife/38877/|accessdate=5 July 2016|agency=Financial Express|date=4 February 2015|archive-url=https://web.archive.org/web/20150926050202/http://www.financialexpress.com/article/markets/dilip-shanghvis-mother-gifts-sun-pharma-shares-to-his-wife/38877/|archive-date=26 September 2015|url-status=dead}}</ref> Shanghvi earned a [[Bachelor of Commerce]] degree from the [[University of Calcutta]].<ref name="Forbes tag">{{cite web|title=Forbes – Dilip Shanghvi|url=https://www.forbes.com/profile/dilip-shanghvi/|publisher=Forbes|accessdate=31 August 2014}}</ref> He spent his childhood and college life with his parents in the [[Burrabazar]] locality of Calcutta. He is an alumnus of [[J. J. Ajmera High School]] and [[Bhawanipur Education Society College]], where he did his schooling and graduation, respectively.<ref>{{cite news|title=The Rise of a Common Man: Dilip Shanghavi - KnowStartup|url=http://knowstartup.com/2015/08/the-rise-of-dilip-shanghavi/|accessdate=19 April 2018|work=KnowStartup|date=4 August 2015}}</ref><ref>{{cite web|title=Dilip Shanghvi- From start up to India's largest drug maker|url=http://www.bigpharmasuccessstories.com/2016/12/07/dilip-shanghvi-from-start-up-to-indias-largest-drug-maker/|accessdate=19 April 2018}}</ref><ref name=zee>{{cite news|title=Govt appoints Dilip Shanghvi, PK Monhanty at RBI’s central board|url=http://www.zeebiz.com/india/news-govt-appoints-dilip-shanghvi-pk-monhanty-at-rbi-s-central-board-35736|accessdate=30 April 2018|work=Zee Business|date=25 January 2018|language=en}}</ref>


== Career ==
== Career ==
He started by helping his father in his wholesale generic drugs business in [[Kolkata]].<ref name=dna/> It was during this work that he thought of manufacturing his own drugs instead of selling others' products.<ref name=dna/>
He started by helping his father in his wholesale generic drugs business in [[Kolkata]].<ref name=dna/> It was during this work that he thought of manufacturing his own drugs instead of selling others' products.<ref name=dna/>


Shanghvi started Sun Pharmaceutical Industries with capital of [[Indian rupee|INR]] 10,000 in 1982 at [[Vapi]], with one psychiatry drug.<ref name=dna/><ref name=BBProfile/> In 1997, Sun acquired [[Caraco Pharma]], a loss-making American company, with the aim of expanding Sun's reach in the United States.{{Citation needed|date=November 2016}} Sun also acquired Israel's Taro Pharma in 2007.<ref name="BS-14">{{cite news|last1=Balakrishnan|first1=Reghu|title=Newsmaker: Dilip Shanghvi|url=http://www.business-standard.com/article/companies/newsmaker-dilip-shanghvi-114041001381_1.html|accessdate=31 August 2014|work=Business Standard|date=10 April 2014}}</ref> Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of [[Teva Pharmaceuticals]], as his successor;<ref name=BBProfile/> Shangvi became managing director.<ref>Economic Times Bureau May 30, 2012 [http://articles.economictimes.indiatimes.com/2012-05-30/news/31900473_1_taro-pharma-net-profit-israeli-subsidiary Sun Pharma's Dilip Shanghvi steps down in favour of Israel Markov]</ref> In April 2014 Sun, [[Ranbaxy]], and [[Daiichi Sankyo]] (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2billion in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and fifth largest in the world, and made Daiichi the second largest shareholder in Sun.<ref>Economic Times. 11 Apr, 2014 [http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ranbaxy-sun-pharma-merger-deal-may-close-by-2014-end-daiichi-sankyo/articleshow/33617708.cms Ranbaxy-Sun Pharma merger deal may close by 2014 end: Daiichi Sankyo]</ref><ref>BBC 7 April 2014 [https://www.bbc.com/news/business-26917569 Sun Pharmaceutical to acquire Ranbaxy in $4bn deal]</ref><ref name=Fierce>Eric Palmer for FiercePharma Mar 26, 2015 [http://www.fiercepharma.com/regulatory/deal-done-sun-pharma-must-now-fix-ranbaxy-s-deep-problems Deal done, Sun Pharma must now fix Ranbaxy's deep problems]</ref>
Shanghvi started Sun Pharmaceutical Industries with capital of [[Indian rupee|INR]] 10,000 in 1982 at [[Vapi]], with one psychiatry drug.<ref name=dna/><ref name=BBProfile/> In 1997, Sun acquired [[Caraco Pharma]], a loss-making American company, with the aim of expanding Sun's reach in the United States.{{Citation needed|date=November 2016}} Sun also acquired Israel's Taro Pharma in 2007.<ref name="BS-14">{{cite news|last1=Balakrishnan|first1=Reghu|title=Newsmaker: Dilip Shanghvi|url=http://www.business-standard.com/article/companies/newsmaker-dilip-shanghvi-114041001381_1.html|accessdate=31 August 2014|work=Business Standard|date=10 April 2014}}</ref> Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of [[Teva Pharmaceuticals]], as his successor;<ref name=BBProfile/> Shanghvi became managing director.<ref>Economic Times Bureau May 30, 2012 [http://articles.economictimes.indiatimes.com/2012-05-30/news/31900473_1_taro-pharma-net-profit-israeli-subsidiary Sun Pharma's Dilip Shanghvi steps down in favour of Israel Markov]</ref> In April 2014 Sun, [[Ranbaxy]], and [[Daiichi Sankyo]] (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2billion in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and fifth largest in the world, and made Daiichi the second largest shareholder in Sun.<ref>Economic Times. 11 Apr, 2014 [http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ranbaxy-sun-pharma-merger-deal-may-close-by-2014-end-daiichi-sankyo/articleshow/33617708.cms Ranbaxy-Sun Pharma merger deal may close by 2014 end: Daiichi Sankyo]</ref><ref>BBC 7 April 2014 [https://www.bbc.com/news/business-26917569 Sun Pharmaceutical to acquire Ranbaxy in $4bn deal]</ref><ref name=Fierce>Eric Palmer for FiercePharma Mar 26, 2015 [http://www.fiercepharma.com/regulatory/deal-done-sun-pharma-must-now-fix-ranbaxy-s-deep-problems Deal done, Sun Pharma must now fix Ranbaxy's deep problems]</ref>


As of January 2019, he had a net worth of $8.6 billion.<ref name="Padma Awards 2016" />
As of January 2019, he had a net worth of $8.6 billion.<ref name="Padma Awards 2016" />
Line 33: Line 33:


==Personal life==
==Personal life==
He is married to Vibha Sanghvi.<ref name=ft/><ref>{{cite news|url=http://articles.economictimes.indiatimes.com/2014-04-08/news/48971238_1_sun-pharmaceutical-industries-novartis-india-dilip-s-shangh|title=Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touch|last=|first=|date=8 April 2014|work=|agency=Economic Times|access-date=|via=}}</ref> They have a son, Aalok and a daughter, Vidhi, both of whom work for Sun Pharmaceuticals.<ref>{{cite news|title=Sun rises on Ranbaxy |url=http://indiatoday.intoday.in/story/dilip-shanghvi-ceo-sun-pharma-ranbaxy-laboratories/1/356394.html|accessdate=5 July 2016|agency=India Today|date=18 April 2014}}</ref>
He is married to Vibha Shanghvi.<ref name=ft/><ref>{{cite news|url=http://articles.economictimes.indiatimes.com/2014-04-08/news/48971238_1_sun-pharmaceutical-industries-novartis-india-dilip-s-shanghvi|title=Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touch|last=|first=|date=8 April 2014|work=|agency=Economic Times|access-date=|via=}}</ref> They have a son, Aalok and a daughter, Vidhi, both of whom work for Sun Pharmaceuticals.<ref>{{cite news|title=Sun rises on Ranbaxy |url=http://indiatoday.intoday.in/story/dilip-shanghvi-ceo-sun-pharma-ranbaxy-laboratories/1/356394.html|accessdate=5 July 2016|agency=India Today|date=18 April 2014}}</ref>


==See also==
==See also==

Revision as of 15:20, 28 September 2019

Dilip Shanghvi
Born (1955-10-01) 1 October 1955 (age 69)
Amreli, Gujarat, India[1]
NationalityIndian
Alma materBhawanipur Education Society College, University of Calcutta
Occupation(s)Founder and MD of Sun Pharmaceuticals
SpouseVibha Shanghvi
Children2

Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman and one of the country's richest people. He founded Sun Pharmaceuticals.[3] The Government of India awarded him the civilian honour of the Padma Shri in 2016.[4] India Today magazine ranked him 8th in India's most powerful people of 2017 list.[5]

Early life

Dilip Shanghvi hails from a Gujarati Kapol Vaishnav family [6][7] family, who was born in the small town of Amreli in Gujarat to Shantilal Shanghvi and Kumud Shanghvi.[1][8] Shanghvi earned a Bachelor of Commerce degree from the University of Calcutta.[9] He spent his childhood and college life with his parents in the Burrabazar locality of Calcutta. He is an alumnus of J. J. Ajmera High School and Bhawanipur Education Society College, where he did his schooling and graduation, respectively.[10][11][12]

Career

He started by helping his father in his wholesale generic drugs business in Kolkata.[1] It was during this work that he thought of manufacturing his own drugs instead of selling others' products.[1]

Shanghvi started Sun Pharmaceutical Industries with capital of INR 10,000 in 1982 at Vapi, with one psychiatry drug.[1][3] In 1997, Sun acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States.[citation needed] Sun also acquired Israel's Taro Pharma in 2007.[13] Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor;[3] Shanghvi became managing director.[14] In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2billion in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and fifth largest in the world, and made Daiichi the second largest shareholder in Sun.[15][16][17]

As of January 2019, he had a net worth of $8.6 billion.[4]

Community

In January 2018, the Indian government appointed Shanghvi to the Reserve Bank of India's 21-member central board committee.[12] He is chairman of the board of governors at IIT Bombay.[18] He was made a trustee of the Rhodes scholarship programme at Oxford University in 2017.[19]

Personal life

He is married to Vibha Shanghvi.[8][20] They have a son, Aalok and a daughter, Vidhi, both of whom work for Sun Pharmaceuticals.[21]

See also

References

  1. ^ a b c d e "From a drug distributor to global pharma tycoon". DNA India. 8 April 2014. Retrieved 9 April 2015.
  2. ^ "Dilip Shanghvi". Forbes. Retrieved 22 February 2018.
  3. ^ a b c "Bloomberg Billionaires: today's ranking of the world's richest people: Dilip Shanghvi". Bloomberg. Retrieved 2 October 2014.
  4. ^ a b "Padma Awards 2016". Press Information Bureau, Government of India. 2016. Retrieved 2 February 2016.
  5. ^ "50 power people". India Today. 14 April 2017.
  6. ^ "Top 10 Gujarati billionaires". India TV News. 1 August 2015.
  7. ^ Das Soma, The Reluctant Billionaire: How Dilip Shanghvi Became the Richest Self-Made Indian, 2019, Penguin, ISBN 9780670088577
  8. ^ a b "Dilip Shanghvi's mother gifts Sun Pharma shares to his wife". Financial Express. 4 February 2015. Archived from the original on 26 September 2015. Retrieved 5 July 2016.
  9. ^ "Forbes – Dilip Shanghvi". Forbes. Retrieved 31 August 2014.
  10. ^ "The Rise of a Common Man: Dilip Shanghavi - KnowStartup". KnowStartup. 4 August 2015. Retrieved 19 April 2018.
  11. ^ "Dilip Shanghvi- From start up to India's largest drug maker". Retrieved 19 April 2018.
  12. ^ a b "Govt appoints Dilip Shanghvi, PK Monhanty at RBI's central board". Zee Business. 25 January 2018. Retrieved 30 April 2018.
  13. ^ Balakrishnan, Reghu (10 April 2014). "Newsmaker: Dilip Shanghvi". Business Standard. Retrieved 31 August 2014.
  14. ^ Economic Times Bureau May 30, 2012 Sun Pharma's Dilip Shanghvi steps down in favour of Israel Markov
  15. ^ Economic Times. 11 Apr, 2014 Ranbaxy-Sun Pharma merger deal may close by 2014 end: Daiichi Sankyo
  16. ^ BBC 7 April 2014 Sun Pharmaceutical to acquire Ranbaxy in $4bn deal
  17. ^ Eric Palmer for FiercePharma Mar 26, 2015 Deal done, Sun Pharma must now fix Ranbaxy's deep problems
  18. ^ "HRD ministry finalises Sun Pharma head as IIT-Bombay chairman". Hindustan Times. 19 March 2016. Retrieved 18 September 2018.
  19. ^ "Rhodes House - Home of The Rhodes Scholarships". Rhodes House - Home of The Rhodes Scholarships. Retrieved 1 April 2018.
  20. ^ "Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touch". Economic Times. 8 April 2014.
  21. ^ "Sun rises on Ranbaxy". India Today. 18 April 2014. Retrieved 5 July 2016.
Quelle: https://en.wikipedia.org/wiki/Special%3ADiff/918416724